Skip to main content
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.950
-0.010 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
1.960
+0.010 (0.51%)
Pre-market: Apr 29, 2026, 4:08 AM EDT

Palisade Bio Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
326.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023250.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bicycle Therapeutics 72.59M
Ovid Therapeutics 7.25M
Compass Therapeutics 850.00K
Silence Therapeutics 559.00K
YD Bio 510.36K
Revenue Rankings

PALI News

More News